Nalmefene Implant in Healthy Subjects

Clinical trial NCT07325279 · RECRUITING

Trial details

NCT number: NCT07325279
Sponsor: ReacX Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Opioid Abuse and Addiction

Start date: 2026-02-23
Primary completion: 2026-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.